References
- Ajouz B., Berrier C., Garrigues A., Besnard M., Ghazi A. Release of thioredoxin via the mechanosensitive channel MscL during osmotic downshock of Escherichia coli cells. J. Biol. Chem. 1998; 273: 26670–26674
- Andresen T. L., Jensen S. S., Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog. Lipid Res. 2005; 44: 68–97
- Anishkin A., Chiang C. S., Sukharev S. Gain-of-function mutations reveal expanded intermediate states and a sequential action of two gates in MscL. J. Gen. Physiol. 2005; 125: 155–170
- Asokan A., Cho M. J. Exploitation of intracellular pH gradients in the cellular delivery of macromolecules. J. Pharm. Sci. 2002; 91: 903–913
- Bally M. B., Lim H., Cullis P. R., Mayer L. D. Controlling the drug delivery attributes of lipid-based drug formulations. J. Liposomes Res. 1998; 8: 299–335
- Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965; 13: 238–252
- Berrier C., Coulombe A., Houssin C., Ghazi A. A patch-clamp study of ion channels of inner and outer membranes and of contact zones of E. coli, fused into grant liposomes. Pressure-activated channels are localized in the inner membrane. FEBS Lett. Dec 18, 1989; 259(1)27–32
- Blount P., Sukharev S. I., Moe P. C., Schroeder M. J., Guy H. R., Kung C. Membrane topology and multimeric structure of a mechanosensitive channel protein of Escherichia coli. EMBO J. 1996; 15: 4798–4805
- Bochet C. G. Photolabile protecting groups and linkers. J. Chem. Soc. Perkin Trans. 2002; 1: 125–142
- Chandra B., Subramaniam R., Mallik S., Srivastava D. K. Formulation of photocleavable liposomes and the mechanism of their content release. Org. Biomol. Chem. 2006; 4: 1730–1740
- Chu C. J., Szoka F. C. pH-sensitive liposomes. J. Liposome Res. 1994; 4: 361–395
- Cruickshank C. C., Minchin R. F., Le Dain A. C., Martinac B. Estimation of the pore size of the large-conductance mechanosensitive ion channel of Escherichia coli. Biophys. J. 1997; 73: 1925–1931
- Dromi S., Frenkel V., Luk A., Traughber B., Angstadt M., Bur M., Poff J., Xie J., Libutti S. K., Li K. C., Wood B. J. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin. Cancer Res. 2007; 13: 2722–2727
- Drummond D. C., Meyer O., Hong K., Kirpotin D. B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmaco. Rev. 1999; 51: 691–744
- Drummond D. C., Zignani M., Leroux J. Current status of pH-sensitive liposomes in drug delivery. Prog. Lipid Res. 2000; 39: 409–460
- Fenske D. B., MacLachlan L., Cullis P. R. Long-circulating vectors for the systemic delivery of genes. Curr. Opin. Mol. Ther. 2001; 3: 153–158
- Gregoriadis G., Wills E. J., Swain C.P., Tavill A. S. Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1974; 1: 1313–1316
- Guo X., Szoka F. C. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc. Chem. Res. 2003; 36: 335–341
- Huang S., Hamilton A. J., Tiukinhoy S. D., Nagaraj A., Kane B. J., Klegerman D. D., McPherson D. D., MacDonald R. C. Liposomes as ultrasound imaging contrast agents and as ultrasound-sensitive drug delivery agents. Cell Mol. Biol. Lett. 2002; 17: 233–235
- Kocer A., Walko M., Bulten E., Halza E., Feringa B. L., Meijberg W. Rationally designed chemical modulators convert a bacterial channel protein into a pH-sensory valve. Angew. Chem. Int. Ed. Engl. 2006; 45: 3126–3130
- Kocer A., Walko M., Feringa B. L. Synthesis and Utilization of reversible and irreversible light-activated nanovalves derived from the channel protein MscL. Nature Protocols 2007; 2: 1426–1437
- Kocer A., Walko M., Meijberg W., Feringa B. L. A light-actuated nanovalve derived from a channel protein. Science 2005; 309: 755–758
- Levina N., Totemeyer S., Stokes N. R., Louis P., Jones M. A., Booth I. R. Protection of Escherichia coli cells against extreme turgor by activation of MscS and MscL mechanosensitive channels: identification of genes required for MscS activity. EMBO J. 1999; 18: 1730–1737
- Meers P. Enzyme-activated targeting of liposomes. Adv. Drug Deliv. Rev. 2001; 53: 265–272
- Perozo E., Kloda A., Cortes D. M., Martinac B. Physical principles underlying the transduction of bilayer deformation forces during mechanosensitive channel gating. Nature Struct. Biol. 2002; 9: 696–703
- Rigaud J. L., Pitard B., Levy D. Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. Biochim. Biophys. Acta 1995; 1231: 223–246
- Thomas J. L., Tirrel D. A. Polyelectrolyte-sensitized phospholipids vesicles. Acc. Chem. Res. 1992; 25: 336–342
- Ulbrich K., Šubr V. Polymeric anticancer drugs with pH-controlled activation. Adv. Drug Deliv. Rev. 2004; 56: 1023–1050
- Van den Bogaart G., Krasnikov V., Poolman B. Dual-color fluorescence-burst analysis to probe protein efflux through the mechanosensitive channel MscL. Biophys. J. 2007; 92: 1233–1240
- Woodle M. C., Lasic D. D. Sterically stabilized liposomes. Biochim. Biophys. Acta 1992; 1113: 171–199
- Yoshimura K., Batiza A., Kung C. Chemically charging the pore constriction opens the mechanosensitive channel MscL. Biophys. J. 2001; 80: 2198–2206
- Yoshimura K., Batiza A., Schroeder M., Blount P., Kung C. Hydrophilicity of a single residue within MscL correlates with increased channel mechanosensitivity. Biophys. J. 1999; 77: 1960–1972
- Zhang J. Q., Zhang Z. R., Yang H., Tan Q. Y., Qin S. R., Qiu X. L. Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm. Res. 2005; 22: 573–583